Western Pacific Wealth Management, LP Bristol Myers Squibb CO Transaction History

Western Pacific Wealth Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $27,536 - $32,858	-568 Reduced 63.25%	330 $16,000
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $3,567 - $3,961	-56 Reduced 5.87%	898 $57,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $8,345 - $9,465	127 Added 15.36%	954 $66,000
Q4 2022 Feb 03, 2023	BUY	$68.48 - $81.09 $19,105 - $22,624	279 Added 50.91%	827 $59,000
Q3 2022 Oct 27, 2022	BUY	$0.13 - $76.84 $63 - $37,805	492 Added 878.57%	548 $38,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $3,003 - $3,501	56 New	56 $3,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Western Pacific Wealth Management, LP, based on Form 13F filings with the SEC.

Stay updated on Western Pacific Wealth Management, LP with notifications on news.